Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 1Solid Tumor 1Hepatitis B 1Gallstones 1Depression 1Condylomata Acuminata 1Carcinoma, Hepatocellular 1Anxiety Disorders 1

Interventions

Colposcopy 13Imiquimod 12Conization 11Papillomavirus Vaccines 8Cryotherapy 6Vaccines 5Papanicolaou Test 4Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4Acetic Acid 4Watchful Waiting 3Vaginal Smears 3Surveys and Questionnaires 3Biopsy 3human papillomavirus vaccine, L1 type 16, 18 2Spectrometry, Fluorescence 2Proflavine 2Mass Screening 2Immunohistochemistry 2Human Papillomavirus DNA Tests 2High-Throughput Screening Assays 2Flow Cytometry 2Curcumin 2Blood Specimen Collection 2pembrolizumab 1nimotuzumab 1lime 1human papillomavirus vaccine, TA 1hecolin 1efineptakin alfa 1Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Uterine Cervical Dysplasia × Hepatitis B Vaccines × Clear all
NCT01356823 2016-01-05

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Xiamen University

Phase 2 Completed
1,600 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡